Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis. (Q48747897)

15 February 2018

title

Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis. (English)

1 reference

15 February 2018

0 references

1 reference

J Iwamoto

1

1 reference

15 February 2018

K Makita

2

1 reference

15 February 2018

Y Sato

3

1 reference

15 February 2018

T Takeda

4

1 reference

15 February 2018

H Matsumoto

5

1 reference

15 February 2018

language of work or name

English

0 references

publication date

23 November 2010

1 reference

15 February 2018

Osteoporosis International

published in

1 reference

15 February 2018

volume

22

1 reference

15 February 2018

issue

10

1 reference

15 February 2018

page(s)

2735-2742

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00198-010-1495-8

exact match

0 references

cites work

Molecular mechanisms of action of bisphosphonates.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Synthesis of eel-calcitonin and (asu1,7)-eel-calcitonin: contribution of the disulfide bond to the hormonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Alendronate improves QOL of postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Diagnostic criteria for primary osteoporosis: year 2000 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

The Face Scale: a brief, nonverbal method for assessing patient mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Ovariectomy-induced hyperalgesia and antinociceptive effect of elcatonin, a synthetic eel calcitonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Analgesic effect of two calcitonins and in vitro interaction with opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Comparison of effects of alendronate and raloxifene on lumbar bone mineral density, bone turnover, and lipid metabolism in elderly women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Alendronate in the treatment of avascular necrosis of the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Sensory innervation of lumbar vertebral bodies in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Fracture prediction from bone mineral density in Japanese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1495-8

Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures

21 January 2018

1 reference

12 December 2020

Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments

1 reference

12 December 2020

Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.

1 reference

12 December 2020

Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures

1 reference

12 December 2020

Characteristics of sensory dorsal root ganglia neurons innervating the lumbar vertebral body in rats

1 reference

12 December 2020

Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)

1 reference

12 December 2020

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain

1 reference

12 December 2020

Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures

1 reference

12 December 2020

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Endoneurial injection of TNF-alpha produces neuropathic pain behaviors.

1 reference

12 December 2020

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Sensory and sympathetic innervation of the vertebral endplate in patients with degenerative disc disease

1 reference

12 December 2020

10.1007/S00198-010-1495-8

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

21104227

1 reference

15 February 2018